[
    [
        {
            "time": "2021-01-07",
            "original_text": "益丰药房：全资子公司拟投建益丰大药房第二总部项目",
            "features": {
                "keywords": [
                    "益丰药房",
                    "全资子公司",
                    "第二总部",
                    "投资项目"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "益丰药房：全资子公司拟投建益丰大药房第二总部项目",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-01-07",
            "original_text": "益丰药房：湖南益丰签订项目投资建设合同，拟3亿元投建益丰大药房第二总部项目",
            "features": {
                "keywords": [
                    "益丰药房",
                    "湖南益丰",
                    "投资建设合同",
                    "3亿元",
                    "第二总部"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "益丰药房：湖南益丰签订项目投资建设合同，拟3亿元投建益丰大药房第二总部项目",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 10
            }
        },
        {
            "time": "2021-01-07",
            "original_text": "上海通报不符合规定药品，涉益丰药房高瓴资本旗下公司，其他违规处罚",
            "features": {
                "keywords": [
                    "上海通报",
                    "不符合规定药品",
                    "益丰药房",
                    "高瓴资本",
                    "违规处罚"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "上海通报不符合规定药品，涉益丰药房高瓴资本旗下公司，其他违规处罚",
                "Correlation": 8,
                "Sentiment": 3,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-01-07",
            "original_text": "【东北医药樊翔宇】益丰药房（603939）深度报告：管理精细、扩张稳健，长期业绩值得期待",
            "features": {
                "keywords": [
                    "东北医药",
                    "益丰药房",
                    "管理精细",
                    "扩张稳健",
                    "长期业绩"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "【东北医药樊翔宇】益丰药房（603939）深度报告：管理精细、扩张稳健，长期业绩值得期待",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-01-07",
            "original_text": "中石化将与光伏企业合作，为碳排放达峰贡献力量",
            "features": {
                "keywords": [
                    "中石化",
                    "光伏企业",
                    "碳排放达峰",
                    "合作"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "能源",
                    "环保"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "中石化将与光伏企业合作，为碳排放达峰贡献力量",
                "Correlation": 2,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 3,
                "Duration": 4,
                "Entity_Density": 1,
                "Market_Scope": 7,
                "Time_Proximity": 5,
                "Headline_Structure": 5,
                "Source_Recency": 6
            }
        }
    ]
]